Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × ferric carboxymaltose × Clear all

NCT02469480 2020-10-19

Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.

Phase 2 Completed

Classical hematologyGastrointestinal

Colorectal Neoplasms, Anemia, Iron-Deficiency